BIRC5 and cervical carcinoma: By using a survivin promoter–luciferase reporter system transfected in cervical carcinoma HeLa cells, Nakahara et al. identified YM155 as a small molecule that significantly inhibits survivin expression at both the mRNA and protein levels when used at 10–100 nM levels [104].